Overview
Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft
Status:
Completed
Completed
Trial end date:
2013-02-01
2013-02-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of the present study is to compare the antiarrhythmic and myocardial protective effect between lidocaine, dexmedetomidine, and their combined infusion in subjects undergoing coronary artery bypass graft.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Samsung Medical CenterTreatments:
Anesthetics
Dexmedetomidine
Lidocaine
Criteria
Inclusion Criteria:- Those undergoing off-pump coronary artery bypass graft during the study period in
Samsung Medical Center
Exclusion Criteria:
- Any patients with plasma aldosterone, or glucocorticoid disorder including primary
hyperaldosteronism, renovascular hypertension, rennin-secreting tumor, salt-wasting
renal disease, Cushing syndrome
- Patients with recent exogenous steroid administration or previous diuretics therapy
- Patients with recent myocardial infarction
- Those undergoing unplanned cardiopulmonary bypass during the surgery